CN101678054A - 在外科手术前和/或外科手术后环境中的益生菌 - Google Patents

在外科手术前和/或外科手术后环境中的益生菌 Download PDF

Info

Publication number
CN101678054A
CN101678054A CN200880016429A CN200880016429A CN101678054A CN 101678054 A CN101678054 A CN 101678054A CN 200880016429 A CN200880016429 A CN 200880016429A CN 200880016429 A CN200880016429 A CN 200880016429A CN 101678054 A CN101678054 A CN 101678054A
Authority
CN
China
Prior art keywords
lactobacillus
purposes
medicine
alimentation composition
probiotic bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200880016429A
Other languages
English (en)
Chinese (zh)
Inventor
E·席夫林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Societe dAssistance Technique pour Produits Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dAssistance Technique pour Produits Nestle SA filed Critical Societe dAssistance Technique pour Produits Nestle SA
Publication of CN101678054A publication Critical patent/CN101678054A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Surgery (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN200880016429A 2007-05-18 2008-05-14 在外科手术前和/或外科手术后环境中的益生菌 Pending CN101678054A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07108492.5A EP1992351B1 (en) 2007-05-18 2007-05-18 Lactobacillus johnsonii for prevention of postsurgical infection
EP07108492.5 2007-05-18
PCT/EP2008/055898 WO2008141989A1 (en) 2007-05-18 2008-05-14 Probiotics in a pre- and/or post surgical environment

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201310631541.XA Division CN103623010A (zh) 2007-05-18 2008-05-14 在外科手术前和/或外科手术后环境中的益生菌

Publications (1)

Publication Number Publication Date
CN101678054A true CN101678054A (zh) 2010-03-24

Family

ID=38476047

Family Applications (2)

Application Number Title Priority Date Filing Date
CN200880016429A Pending CN101678054A (zh) 2007-05-18 2008-05-14 在外科手术前和/或外科手术后环境中的益生菌
CN201310631541.XA Pending CN103623010A (zh) 2007-05-18 2008-05-14 在外科手术前和/或外科手术后环境中的益生菌

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201310631541.XA Pending CN103623010A (zh) 2007-05-18 2008-05-14 在外科手术前和/或外科手术后环境中的益生菌

Country Status (15)

Country Link
US (2) US8529887B2 (https=)
EP (2) EP1992351B1 (https=)
JP (2) JP5497634B2 (https=)
CN (2) CN101678054A (https=)
AU (1) AU2008253040B2 (https=)
BR (1) BRPI0811180A2 (https=)
CA (1) CA2686976C (https=)
CL (1) CL2008001446A1 (https=)
DK (1) DK1992351T3 (https=)
ES (1) ES2578261T3 (https=)
MX (1) MX2009012255A (https=)
RU (1) RU2470652C2 (https=)
TW (1) TW200902040A (https=)
WO (1) WO2008141989A1 (https=)
ZA (1) ZA200909002B (https=)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102835657A (zh) * 2011-06-20 2012-12-26 丰华生物科技股份有限公司 用以抑制发炎反应及抗阴道炎的含乳酸菌食品组合物及医药组合物
CN103458887A (zh) * 2011-03-31 2013-12-18 雀巢产品技术援助有限公司 用于增加精氨酸水平的营养组合物及其使用方法
CN103648511A (zh) * 2011-06-08 2014-03-19 有机平衡有限公司 喷雾干燥的乳杆菌属菌株/细胞及其对抗幽门螺杆菌的用途
CN104284975A (zh) * 2012-04-09 2015-01-14 科.汉森有限公司 应用鼠李糖乳杆菌菌株的生物保护
CN104726596A (zh) * 2014-03-28 2015-06-24 首尔大学校产学协力团 利用肠内细菌的菌落和功能的变化的代谢性及炎症性疾病的早期诊断
CN113559131A (zh) * 2021-07-23 2021-10-29 科为博(江苏)生物科技研究院有限公司 一种用于改善肠胃的益生菌粉

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2578261T3 (es) * 2007-05-18 2016-07-22 Nestec S.A. Lactobacillus johnsonii para prevenir infecciones postoperatorias
CA2724554A1 (en) * 2008-05-15 2009-11-19 Youdocs, Llc Methods and systems for improving human health using targeted probiotics
WO2010096550A2 (en) * 2009-02-18 2010-08-26 University Of Florida Research Foundation, Inc. Lactobacillus supplement for alleviating type 1 diabetes
WO2010096564A2 (en) * 2009-02-19 2010-08-26 Probiohealth Llc Dietary supplements containing polyunsaturated omega-3 fatty acids and probiotic bacteria with potential gastrointestinal and dermatological benefits
EP2413849B1 (en) 2009-04-03 2014-07-02 Metamodix, Inc. Modular gastrointestinal prostheses
US9173760B2 (en) 2009-04-03 2015-11-03 Metamodix, Inc. Delivery devices and methods for gastrointestinal implants
US9278019B2 (en) 2009-04-03 2016-03-08 Metamodix, Inc Anchors and methods for intestinal bypass sleeves
US8784798B2 (en) * 2009-05-11 2014-07-22 Nestec S.A. Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
EP2251020A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
EP2251022A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Non-replicating micro-organisms and their immune boosting effect
EP2459203B1 (en) * 2009-07-30 2018-10-31 DuPont Nutrition Biosciences ApS Lactic acid bacteria and bifidobacteria for treating endotoxemia
KR101869498B1 (ko) * 2011-04-08 2018-06-22 시에이치알. 한센 에이/에스 시너지적 항균 효과
IN2014DN07752A (https=) 2012-02-29 2015-05-15 Ethicon Endo Surgery Inc
JP6203816B2 (ja) 2012-03-29 2017-09-27 セラバイオーム，エルエルシー 回腸及び虫垂に対して活性の胃腸部位特異的経口ワクチン接種製剤
WO2013153070A1 (en) 2012-04-09 2013-10-17 Chr. Hansen A/S Bioprotection using lactobacillus paracasei strains
EP2945566A4 (en) 2013-01-15 2016-10-26 Metamodix Inc SYSTEM AND METHOD FOR MODIFYING MICROBIAL INTESTINAL FLORA
AU2014239883B2 (en) 2013-03-14 2019-01-17 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
RU2565444C2 (ru) * 2013-11-28 2015-10-20 Федеральное государственное бюджетное учреждение науки Институт клеточного и внутриклеточного симбиоза Уральского отделения Российской академии наук Способ профилактики инфекционно-воспалительных осложнений у женщин с субмукозной миомой матки после гистерорезектоскопии
SG10201903823QA (en) 2014-10-31 2019-05-30 Whole Biome Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
US9622897B1 (en) 2016-03-03 2017-04-18 Metamodix, Inc. Pyloric anchors and methods for intestinal bypass sleeves
WO2017201424A1 (en) 2016-05-19 2017-11-23 Metamodix, Inc. Pyloric anchor retrieval tools and methods
RU2628063C1 (ru) * 2016-09-22 2017-08-14 федеральное государственное бюджетное образовательное учреждение высшего образования "Тюменский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Тюменский ГМУ Минздрава России) Способ прогнозирования транслокации E.coli из кишечника при некультивируемом типе инфекционного процесса в эксперименте на кроликах
RU2642327C1 (ru) * 2016-10-06 2018-01-24 федеральное государственное бюджетное образовательное учреждение высшего образования "Тюменский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Тюменский ГМУ Минздрава России) Способ прогноза развития патогенетического процесса по некультивируемому или культивируемому типу в эксперименте
WO2018112194A1 (en) 2016-12-15 2018-06-21 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for modulating growth of a genetically modified gut bacterial cell
CN111372596A (zh) 2017-08-30 2020-07-03 潘德勒姆治疗公司 用于治疗微生物组相关病症的方法和组合物
CA3106315A1 (en) 2018-07-19 2020-01-23 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment
TWI718402B (zh) * 2018-08-16 2021-02-11 葡萄王生技股份有限公司 副乾酪乳酸桿菌gks6之活性物質、含其之組合物及其促進長壽之用途
TWI784194B (zh) * 2019-09-04 2022-11-21 台達電子工業股份有限公司 抑制具萬古黴素抗藥性腸球菌之益生菌組合與其用途
CN112438995A (zh) 2019-09-04 2021-03-05 台达电子工业股份有限公司 抑制具万古霉素抗药性肠球菌的益生菌及其组合与其用途
US20220193156A1 (en) * 2020-12-23 2022-06-23 Thi Tuyet Mai Ta Preoperative compositions and methods of preparation thereof
US12377123B2 (en) * 2020-12-23 2025-08-05 Preoperative Nutrition Preoperative compositions and methods of preparation thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0768375B2 (fr) * 1992-07-06 2002-06-12 Societe Des Produits Nestle S.A. Bactérie lactique
EP0577903B1 (fr) * 1992-07-06 1997-12-17 Societe Des Produits Nestle S.A. Agent antigastrite
DE69707413T3 (de) * 1997-01-09 2009-07-02 Société des Produits Nestlé S.A. Probiotik enthaltendes Getreideprodukt
IT1289984B1 (it) * 1997-02-27 1998-10-19 Proge Farm Srl Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale
ES2168785T5 (es) 1997-07-05 2009-04-16 Societe Des Produits Nestle S.A. Absorcion de minerales por las celulas intestinales.
RO112995B1 (ro) * 1997-08-05 1998-03-30 Rodica Teodorescu Produs medicamentos pentru terapia colonului
MXPA02009342A (es) * 2000-03-24 2003-09-22 Nestle Sa Uso de bacterias de acido lactico para el tratamiento de la peritonitis.
AU5625001A (en) * 2000-04-18 2001-10-30 Societe Des Produits Nestle S.A. Nutritional modules
GB0027761D0 (en) * 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
US20030092163A1 (en) 2001-07-26 2003-05-15 Collins John Kevin Probiotic bifidobacterium strains
SI1565547T2 (sl) * 2002-06-28 2013-02-28 Biosearch S.A. Probiotiäśni sevi, postopek za izbiranje le-teh, njihovi sestavki in njihova uporaba
PL1638416T3 (pl) * 2003-06-23 2013-09-30 Nestec Sa Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej
KR20060109452A (ko) * 2003-10-02 2006-10-20 더 바이오 밸런스 코포레이션 건조 바이오치료 조성물, 용도, 그 투여 장치 및 투여 방법
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
EP1807097A2 (en) * 2004-10-29 2007-07-18 N.V. Nutricia Peri-operative composition comprising lactobacillus rhamnosus
US7595079B2 (en) * 2005-07-08 2009-09-29 Bomac Vets Plus, Inc. Nutritional conjunctive support therapy for recovery in animals following stress or illness
RU2293568C1 (ru) * 2006-01-10 2007-02-20 Федеральное государственное учреждение Российский центр функциональной хирургической гастроэнтерологии Федерального агентства по здравоохранению и социальному развитию (ФГУ "РЦФХГ Росздрава") Способ периоперационной коррекции дисбиоза толстой кишки у больных колоректальным раком
ES2578261T3 (es) * 2007-05-18 2016-07-22 Nestec S.A. Lactobacillus johnsonii para prevenir infecciones postoperatorias

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103458887A (zh) * 2011-03-31 2013-12-18 雀巢产品技术援助有限公司 用于增加精氨酸水平的营养组合物及其使用方法
CN103648511A (zh) * 2011-06-08 2014-03-19 有机平衡有限公司 喷雾干燥的乳杆菌属菌株/细胞及其对抗幽门螺杆菌的用途
CN103648511B (zh) * 2011-06-08 2018-12-07 诺沃奇梅兹有限公司 喷雾干燥的乳杆菌属菌株/细胞及其对抗幽门螺杆菌的用途
CN102835657A (zh) * 2011-06-20 2012-12-26 丰华生物科技股份有限公司 用以抑制发炎反应及抗阴道炎的含乳酸菌食品组合物及医药组合物
CN102835657B (zh) * 2011-06-20 2014-08-20 丰华生物科技股份有限公司 用以抑制发炎反应及抗阴道炎的含乳酸菌食品组合物及医药组合物
CN104284975A (zh) * 2012-04-09 2015-01-14 科.汉森有限公司 应用鼠李糖乳杆菌菌株的生物保护
CN104284975B (zh) * 2012-04-09 2016-08-24 科.汉森有限公司 应用鼠李糖乳杆菌菌株的生物保护
CN104726596A (zh) * 2014-03-28 2015-06-24 首尔大学校产学协力团 利用肠内细菌的菌落和功能的变化的代谢性及炎症性疾病的早期诊断
CN113559131A (zh) * 2021-07-23 2021-10-29 科为博(江苏)生物科技研究院有限公司 一种用于改善肠胃的益生菌粉

Also Published As

Publication number Publication date
CN103623010A (zh) 2014-03-12
BRPI0811180A2 (pt) 2014-10-21
MX2009012255A (es) 2009-11-25
TW200902040A (en) 2009-01-16
US20100135971A1 (en) 2010-06-03
DK1992351T3 (en) 2016-06-06
ES2578261T3 (es) 2016-07-22
JP5497634B2 (ja) 2014-05-21
CA2686976C (en) 2015-02-17
EP2146729A1 (en) 2010-01-27
EP1992351A1 (en) 2008-11-19
RU2009147036A (ru) 2011-06-27
WO2008141989A1 (en) 2008-11-27
CL2008001446A1 (es) 2009-10-02
US8529887B2 (en) 2013-09-10
AU2008253040B2 (en) 2014-06-12
JP6285108B2 (ja) 2018-02-28
AU2008253040A1 (en) 2008-11-27
CA2686976A1 (en) 2008-11-27
US20130344044A1 (en) 2013-12-26
EP1992351B1 (en) 2016-05-11
US9616094B2 (en) 2017-04-11
JP2013216658A (ja) 2013-10-24
RU2470652C2 (ru) 2012-12-27
JP2010527343A (ja) 2010-08-12
ZA200909002B (en) 2011-02-23

Similar Documents

Publication Publication Date Title
EP1992351B1 (en) Lactobacillus johnsonii for prevention of postsurgical infection
US12357647B2 (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
CN1239096C (zh) 营养组合物
US11135232B2 (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
CN102159226B (zh) 增加剖宫产出生婴儿的IgA分泌的益生菌
AU2008324105B2 (en) Use of oligosaccharides containing N-acetyllactosamine for maturation of immune responses in neonates
TW200900075A (en) Method for treating or preventing systemic inflammation
TW200936147A (en) Prevention and treatment of secondary infections following viral infection
CN102006788A (zh) 合益素混合物
CA3116039C (en) Human dietary supplement and method for treating digestive system and immune-related disorders
AU2005232497B2 (en) Preventive and/or therapeutic agent for inflammatory bowel diseases
WO2025099321A1 (en) Compositions comprising human milk oligosaccharides and inactivated cells of a microorganism
HK1227299A (en) Product containing inactivated probiotic for children or infants
HK1227299A1 (en) Product containing inactivated probiotic for children or infants
HK1141729B (en) Method for treating or preventing systemic inflammation
HK1140430A (en) Product containing inactivated probiotic for children or infants

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20100324